Hadron Energy (HDRN) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
5 Oct, 2026Company overview and business model
Newly organized Cayman Islands SPAC formed to acquire one or more businesses; no target selected and no substantive target discussions reported as of July 9, 2024.
Search may span industries and regions, with intended focus on TMT, AI/ML, cybersecurity, MedTech, semiconductors and sustainable industries.
Target strategy favors established, mid-market businesses with differentiated technology, strong management and growth and margin-expansion potential; post-combination plans include operational support and follow-on acquisitions.
Financial performance and metrics
May 31, 2024: cash and total assets $100,000; liabilities $17,652; working capital and shareholders’ equity $82,348.
From May 8 to May 31, 2024, recorded $17,652 general and administrative expense and net loss; no revenue or operating activity.
Auditor cited substantial doubt about going-concern status; May 31 cash and working capital were insufficient to fund planned activities for the upcoming year without financing.
Pro forma dilution is estimated at $10.13 per share, or 101.3%, for non-redeeming public investors without the over-allotment option.
Use of proceeds and capital allocation
Plans to place $250 million, or $287.5 million with full over-allotment, in trust; permitted investments are short-term U.S. Treasury securities or qualifying Treasury money-market funds.
Estimated $2.05 million outside trust, including existing cash, allocated to deal expenses, reporting, office and administrative fees, D&O insurance, CFO payments and working capital over up to 24 months.
Trust funds are intended for a business combination, redemptions and transaction expenses; unused funds after a combination may support operations, debt repayment, acquisitions or working capital.
Latest events from Hadron Energy
- Higher costs cut Q1 net income; merger closing hinges on cash, approvals and redemptions.HDRN
Q1 2026 - A $250 million blind-pool IPO pairs a 21-month deadline with steep dilution and conflicts.HDRN
Registration filing - IPO proceeds reached $200.0 million; a business-combination target remains unselected.HDRN
Q3 2024 - Trust interest drove SPAC income as the microreactor target remained loss-making and pre-commercial.HDRN
Q4 2025 - Trust interest lifted Q1 profit as target search and going-concern risks persist.HDRN
Q1 2025 - 25M-unit IPO filing amended solely to add exhibits, with a 3.75M-unit option.HDRN
Registration filing - Trust income drove earnings, but no target and limited operating cash sustain execution risk.HDRN
Q2 2025 - $250M SPAC, no target selected, 24-month deadline and material dilution risks.HDRN
Registration filing - A microreactor commercialization plan meets a large resale overhang and acute funding risk.HDRN
Registration filing